TableĀ 2

Adherence of studies to modified CONSORT-NPT checklist

CONSORT numberPointOverall adherence, n (%)Medical adherence, n (%)Surgical adherence, n (%)
1aTitle and abstract46 (85)17 (77)29 (91)
1b7 (13)*7 (32)0
2aBackground and objectives54 (100)22 (100)32 (100)
2b54 (100)22 (100)32 (100)
3aTrial design22 (41)14 (64)8 (25)
3b54 (100)22 (100)32 (100)
4aParticipants54 (100)22 (100)32 (100)
4b13 (24)*7 (32)6 (19)
5Interventions48 (89)19 (86)29 (91)
5a39 (72)20 (91)19 (59)
5b50 (93)20 (91)30 (94)
5c7 (13)*6 (27)1 (3)
6aOutcomes48 (89)22 (100)26 (81)
6b54 (100)22 (100)32 (100)
7aSample size3 (6)*2 (9)1 (3)
7b52 (96)22 (100)30 (94)
8aRandomisation sequence generation30 (56)12 (55)18 (56)
8b9 (17)*2 (9)7 (22)
9Allocation concealment mechanism28 (52)17 (77)11 (34)
10Randomisation implementation18 (33)13 (59)5 (16)
11aBlinding29 (54)16 (73)13 (41)
11b30 (56)16 (73)14 (44)
12aStatistical methods54 (100)22 (100)32 (100)
12b2 (4)*02 (6)
13aParticipant flow0*00
13b51 (94)22 (100)29 (91)
NewImplementation of intervention38 (70)12 (55)26 (81)
14aRecruitment48 (89)22 (100)26 (81)
14b51 (94)22 (100)29 (91)
15aBaseline data52 (96)22 (100)30 (94)
15b0*00
16Numbers analysed52 (96)22 (100)30 (94)
17aOutcomes and estimation21 (39)18 (82)3 (9)
17b15 (28)*14 (64)1 (3)
18Ancillary analyses42 (78)20 (91)22 (29)
19Harms51 (94)21 (95)30 (94)
20Limitations35 (65)19 (86)16 (50)
21Generalisability24 (44)14 (64)10 (31)
22Interpretation51 (94)22 (100)29 (91)
23Registration49 (91)22 (100)27 (84)
24Protocol25 (46)18 (82)7 (22)
25Funding40 (74)22 (100)18 (56)
  • Headings in italics are covered within the CONSORT-NPT extension. Non-italics are exclusive to CONSORT 2010 statement. Further details available in online supplementary appendix S3.